IMTX
#2301
Immatics N.V. - Ordinary Shares
9.5 3 USD
+0.01%
Market Price
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
Jahresspanne
Tagesänderung
+0.85%
Monatliche Änderung
+10.56%
6 month change
-5.55%
Jahresänderung
-7.92%
Vorheriger Schlusskurs
9.4 5
Open
9.5 3
Tief
9.5 3
Hoch
9.5 3
Volumen
36
Financials
- Market Capitalization 1.28 B
- Employee 407
- Founded 2000
- CEO Harpreet Singh
- Website www.immatics.com
- Headquarter Netherlands
- FIGI N/A
- Industry Biotechnologie
Related tickers
| # | Name | Preis | 24h % | 7d % | 1M % | 1J % | Marktkapitalisierung | Letzte 7 Tage | |
|---|---|---|---|---|---|---|---|---|---|
| 2296 |  MNKD MannKind Corporation - Common Stock | 4.01 USD | +1.52% | -2.20% | +1.26% | -24.34% | 1.29 B USD | ||
| 2298 |  MLTX MoonLake Immunotherapeutics - Class A Ordinary Shares | 15.05 USD | +0.40% | -3.15% | -18.65% | +57.43% | 1.28 B USD | ||
| 2317 |  DRTS Alpha Tau Medical Ltd. - Ordinary Shares | 14.11 USD | -3.62% | -4.27% | +22.38% | +315.00% | 1.24 B USD | ||
| 2339 |  GLUE Monte Rosa Therapeutics, Inc. - Common Stock | 13.94 USD | +4.19% | -0.85% | -16.23% | +23.36% | 1.19 B USD |